0001209191-15-007710.txt : 20150130 0001209191-15-007710.hdr.sgml : 20150130 20150130093235 ACCESSION NUMBER: 0001209191-15-007710 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150129 FILED AS OF DATE: 20150130 DATE AS OF CHANGE: 20150130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AUXILIUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001182129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 233016883 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19087 BUSINESS PHONE: 484 321 5900 MAIL ADDRESS: STREET 1: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19087 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKEE WILLIAM CENTRAL INDEX KEY: 0001237262 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36628 FILM NUMBER: 15560988 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-29 0 0001182129 AUXILIUM PHARMACEUTICALS INC AUXL 0001237262 MCKEE WILLIAM C/O AUXILIUM PHARMACEUTICALS, INC. 640 LEE ROAD CHESTERBROOK PA 19087 1 0 0 0 Common Stock 2015-01-29 4 J 0 10000 36.53 D 0 D Nonqualified Stock Option (Right to Buy) 25.99 2015-01-29 4 J 0 15000 36.53 D 2010-06-10 2019-06-09 Common Stock 15000 0 D Nonqualified Stock Option (Right to Buy) 29.72 2015-01-29 4 J 0 15000 36.53 D 2011-06-16 2020-06-02 Common Stock 15000 0 D Nonqualified Stock Option (Right to Buy) 19.78 2015-01-29 4 J 0 15000 36.53 D 2012-06-21 2021-06-15 Common Stock 15000 0 D Nonqualified Stock Option (Right to Buy) 24.62 2015-01-29 4 J 0 5000 36.53 D 2013-05-01 2022-06-20 Common Stock 5000 0 D Nonqualified Stock Option (Right to Buy) 14.37 2015-01-29 4 J 0 5000 36.53 D 2014-05-21 2023-04-30 Common Stock 5000 0 D Nonqualified Stock Option (Right to Buy) 20.44 2015-01-29 4 J 0 5000 36.53 D 2015-05-21 2024-05-20 Common Stock 5000 0 D In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these deferred stock units were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement. In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these options were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement. /s/ Michael J. Purvis, as attorney-in-fact on behalf of William T. McKee 2015-01-30